Temporal Trends of Invasive Disease Due to Streptococcus pneumoniae among Children in the Intermountain West: Emergence of Nonvaccine Serogroups
Author(s) -
Carrie L. Byington,
Matthew H. Samore,
Gregory J. Stoddard,
Sarah E. Barlow,
Judy A. Daly,
Kent Korgenski,
Sean D. Firth,
David W. Glover,
Jørgen Skov Jensen,
Edward O. Mason,
Cheryl K. Shutt,
Andrew T. Pavia
Publication year - 2005
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/430604
Subject(s) - streptococcus pneumoniae , medicine , pneumococcal disease , incidence (geometry) , pneumococcal conjugate vaccine , pneumococcal infections , disease , immunology , pediatrics , microbiology and biotechnology , biology , antibiotics , physics , optics
Use of the heptavalent pneumococcal conjugate vaccine (PCV-7 [Prevnar]) has been associated with decreased a incidence of invasive pneumococcal disease (IPD) among children in the United States.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom